Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Pariser

Dermatology Norfolk, VA Medical Doctor

NPI 1417050717 CMS profile 109604

6160 Kempsville Cir Ste 200, Norfolk, VA 23502

Open in the dashboard

General payments

$260,607

484 records reported · program years 2019–2025

Research payments

$106,345

Paid to them · 90 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$6,700,189 paid to institutions, not to them · program years 2019–2025

Through program year 2025, David Pariser of Norfolk, VA is reported in the CMS Open Payments database as having received $260,607 across 484 general payments and $106,345 in research payments paid to them. Separately, studies naming them as principal investigator received $6,700,189 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,753 33
2024 General $4,997 49
2024 Research $1,093 10
2023 General $23,952 64
2023 Research $3,383 16
2022 General $21,834 76
2022 Research $6,152 8
2021 General $57,849 64
2021 Research $10,251 14
2020 General $45,759 45
2020 Research $29,446 12
2019 General $96,464 153
2019 Research $56,020 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Pariser
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to David Pariser were reported at $9,753. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year David Pariser Dermatology median Middle half National median
2019 $96,464 $454 $129–$1,240 $163
2020 $45,759 $235 $81–$756 $114
2021 $57,849 $377 $108–$1,108 $132
2022 $21,834 $514 $143–$1,391 $149
2023 $23,952 $607 $159–$1,674 $160
2024 $4,997 $751 $204–$1,903 $164
2025 $9,753 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Regeneron Healthcare Solutions, Inc. $38,532 32 payments
  2. LEO Pharma Inc. $28,308 20 payments
  3. Genzyme Corporation $26,278 17 payments
  4. AbbVie, Inc. $23,894 118 payments
  5. E.R. Squibb & Sons, L.L.C. $18,310 43 payments
  6. Janssen Biotech, Inc. $17,290 28 payments
  7. Novartis Pharmaceuticals Corporation $15,278 22 payments
  8. Lilly USA, LLC $13,182 57 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $12,180 8 payments
  10. Janssen Scientific Affairs, LLC $10,957 18 payments
  11. Other $56,397 121 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $213,738 80 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,710 46 payments
  3. Travel and Lodging $15,955 35 payments
  4. Food and Beverage $11,486 319 payments
  5. Honoraria $2,500 1 payment
  6. Education $218 3 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT Inflammation And Immunology $38,498 32 payments
  2. TREMFYA $18,197 29 payments
  3. DUPIXENT Immunology $16,119 19 payments
  4. DUPIXENT Immunology $11,873 3 payments
  5. XEPI $8,957 10 payments
  6. REMICADE $8,700 16 payments
  7. COSENTYX $7,522 9 payments
  8. SKYRIZI $5,685 28 payments
  9. Ameluz $5,598 3 payments
  10. BF-RhodoLED $5,598 3 payments
  11. Other $32,675 230 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. E.R. Squibb & Sons, L.L.C. $35,250 6 payments
  2. Bausch Health US, LLC $23,400 4 payments
  3. Eli Lilly and Company $17,455 12 payments
  4. Regeneron Pharmaceuticals, Inc. $14,128 29 payments
  5. Novartis Pharmaceuticals Corporation $9,788 12 payments
  6. AbbVie, Inc. $4,372 25 payments
  7. LEO Pharma AS $1,875 1 payment
  8. Biofrontera Inc. $78 1 payment

Records

574 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record